ACM
NVS icon

Americafirst Capital Management’s Novartis NVS Stock Holding History

Americafirst Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,858
Closed -$456K – 195
2017
Q1 		$456K Buy
+6,858
New +$457K 0.54% 54

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Americafirst Capital Management's NVS Position: Q2 2017 in Review

Americafirst Capital Management sold out of Novartis (NVS) in Q2 2017, closing a stake of 6,858 shares — an estimated $456K sold.

Americafirst Capital Management first reported a position in NVS in Q1 2017 and held it in 1 quarter. The position peaked at $456K in Q1 2017. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

  • Americafirst Capital Management reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
  • Americafirst Capital Management sold 6,858 Novartis shares in Q2 2017, an estimated $456K.
  • Americafirst Capital Management first reported a position in Novartis in Q1 2017 and held it in 1 quarter.
  • Americafirst Capital Management's Novartis position peaked at $456K in Q1 2017.
  • 920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Americafirst Capital Management's 13F filing for Q2 2017, filed 15 Aug 2017.